Showing 1–20 of 20
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent Canon (7751.T) group FY2025 revenue ¥4.62tn (+2.5%); operating margin 9.8%; net income ¥332.1bn.
Medical unit: sales ¥580.6bn (+2.1%), operating profit ¥32.8bn (prior-year loss).
FY2025 revenue €22.46bn (+1.7%); operating margin 9.8%; net income €1.60bn.
Net debt rose to €5.31bn after acquisitions.
FY2026 revenue $254.25bn (+14.0%); operating margin 1.0%; net income $1.71bn.
Cash $4.86bn; debt $8.89bn.
Listed (CCLD).
Latest full-year results not yet captured by HSH.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue €649.2m (-0.8%); operating margin 4.7%; net income €9.4m.
Balance sheet figures not captured from release.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue C$15.91bn (+8.4%); pre-tax margin 14.1%; net income C$1.66bn.
Net debt C$3.45bn; long-term debt and leases C$4.33bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2026 revenue $63.33bn (+12.0%); operating margin 24.3%; net income $13.27bn.
Cash $15.92bn; debt $29.53bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Recent change of ownership; current owner not yet confirmed from official filings.
Financial health not assessed until ownership and accounts are verified.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue €1.21bn (+5.0%).
Revenue +5% (organic +5%). Profit figures not yet captured.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2026 revenue $4.81bn (+21.7%); operating margin -6.1%; net loss $162.5m.
Cash $5.23bn; debt $745.5m.